Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RCEL · against 452 other Healthcare companies of similar size
Ranked #444 of 453 · scores higher than 2% of peers · safety percentile 1
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)47 peers with a safety percentile of 0–9, including RCEL · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RCEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 421 reported | Not reported | 0.18× | — | — | 33% |
| BetaLower is better · 434 reported | 2.02 | 0.43 | 5% | 33% | |
| Current ratioHigher is better · 446 reported | 0.41× | 2.88× | 1% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 440 | 301M USD | 3 | 67 | |
| 441 | 3.9B SEK (≈$385M) | 2 | 23 | |
| 442 | 825M USD | 2 | 24 | |
| 443 | 289M USD | 1 | 57 | |
| 444 | 474M USD | 1 | 25 | |
| 445 | 693M USD | 1 | ||
| 446 | 615M USD | 1 | 48 | |
| 447 | 253M USD | 1 | 15 | |
| 448 | 555M EUR (≈$611M) | 1 | 25 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score